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Microbial biofilms demonstrate a decreased susceptibility to
antimicrobial agents. Various mechanisms have been proposed
to be involved in this recalcitrance. We focus on two of these
factors. Firstly, the ability of sessile cells to actively mediate
efflux of antimicrobial compounds has a profound impact on
resistance and tolerance, and several studies point to the exist-
ence of biofilm-specific efflux systems. Secondly, biofilm-spe-
cific stress responses have a marked influence on cellular phys-
iology, and contribute to the occurrence of persister cells. We
provide an overview of the data that demonstrate that both pro-
cesses are important for survival following exposure to antimi-
crobial agents.
Microbial biofilms are surface-attached communities, con-
sisting of cells embedded in an extracellular polymeric matrix
that is at least partially composed of polymers produced by the
microorganism themselves (1). Biofilms are omnipresent in
natural and man-made environments (1, 2), and biofilm-asso-
ciated bacteria are involved in a wide range of infections,
including respiratory tract infections in cystic fibrosis (CF)2
patients, chronically infectedwounds, and device-related infec-
tions (3, 4). One of the hallmarks of these biofilm-associated
infections is the frequent failure of antimicrobial chemother-
apy. Although it is often postulated that sessile cells are more
resistant to antimicrobial agents, these cells typically do not
grow better than planktonic cells in the presence of antibiotics;
for example, biofilm-associated and stationary-phase plank-
tonic Burkholderia cepacia complex bacteria showed similar
susceptibilities to antibiotics (5). However, it is muchmore dif-
ficult to kill biofilm-associated cells than planktonic cells (6),
and various mechanisms that potentially could be involved in
this have been described in the literature (see Refs. 7 and 8 for
recent reviews as well as Refs. 9 and 10 in this minireview
series). Avoiding exposure to (sufficiently high concentrations
of) antibiotics, and the presence of a small population of spe-
cialized survivor cells that are tolerant toward particular anti-
microbial agents (i.e. they are not killed upon exposure to the
product) are two important mechanisms that will be discussed
in this review.
The Role of Efflux in Biofilm Resistance
Bacteria use specialized membrane-associated proteins to
expel a wide range of compounds from the cytoplasm (11).
Combined with reduced influx of these compounds and/or
enzymatic degradation, efflux pumps are responsible for keep-
ing the cytoplasmic concentrations of certain antimicrobial
compounds below a critical threshold (11, 12). Bacterial efflux
pumps can be divided into several superfamilies, withmembers
of the RND family being the most studied when it comes to
their involvement in bacterial biofilm resistance and/or biofilm
formation. They are composed of an innermembrane protein, a
periplasmicmembrane fusion protein, and an outer membrane
protein (13, 14). This complex spans the Gram-negative cell
envelope and allows the efficient translocation of a wide range
of molecules (supplemental Fig. S1).
Enterobacteriaceae: Escherichia coli, Klebsiella pneumoniae,
and Salmonella
In biofilms formed by two E. coli strains, a considerable frac-
tion of genes up-regulated in biofilms as compared with plank-
tonic cells was shown to be involved in efflux and transport (128
out of 600 up-regulated genes) (15). It was claimed that this
up-regulation was a direct consequence of the “waste manage-
ment problem” occurring in the “cramped conditions” encoun-
tered in the biofilm. When cells of various E. coli strains and a
strain of K. pneumoniae were exposed to the efflux inhibitors
thioridazine, phenyl-arginine--naphthylamide (PAN), or
1-(1-naphthylmethyl)-piperazine (NMP), biofilm formation
was significantly repressed, suggesting that functional efflux
systems are required for full biofilm formation. In addition,
these efflux pump inhibitors increased the activity of tetracy-
cline against biofilms (15). In enteroaggregative E. coli, the
TolC efflux pump is required for adherence to HEp-2 cells and
biofilm formation, probably because it plays an important role
in secreting a yet unidentified factor (16).
Salmonella enterica serovar Typhimurium mutants lacking
any of the known efflux systems also showed a marked reduc-
tion in biofilm formation (17). It was observed that in these
mutants, the expression of several curli genes was down-regu-
lated, and these mutants effectively failed to produce curli. As
curli fimbriae are an important component of the Salmonella
biofilm matrix, and have previously been shown to be involved
in adhesion, cell aggregation, and biofilm formation (18), this
presents a functional connection between efflux and biofilm
formation. Also, in this study, the anti-biofilm effects of inacti-
vating particular efflux systems could be mimicked by adding
efflux pump inhibitors, including PAN, carbonyl cyanide
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m-chlorophenylhydrazone (CCCP), and chlorpromazine. In a
subsequent study, the same authors focused on the S. enterica
serovar Typhimurium AcrAB-TolC system and showed that
AcrA and TolC are involved in biofilm formation, whereas
AcrB is not, and in both the acrA and the tolC mutant, the
expression of structural curli genes and regulatory genes
involved in curli biosynthesis was significantly down-regulated
as compared with the wild type strain (19).
Pseudomonas aeruginosa
The genome of the gamma-proteobacterium P. aeruginosa
contains at least 12 RND pump-encoding operons (20, 21).
Although initial studies on the mexAB-oprM, mexCD-oprJ,
mexEF-oprN, and mexXY efflux systems in P. aeruginosa did
not point to a major role in biofilm resistance, expression of
these efflux systems in biofilms was found to be heterogeneous,
with cells closest to the substrate showing the highest expres-
sion levels (22). This should not come as a surprise, as it is
currently well established that different populations can be
found inmicrobial biofilms, and these subpopulations of sessile
cells are exposed to different chemical and physical environ-
ments, and hence show differences in physiology (for reviews
on this topic, see Refs. 23 and 24). Subsequent investigations
revealed that mexAB-oprM and mexCD-oprJ are essential for
P. aeruginosa biofilm formation in the presence of azithromy-
cin, as a mutant in which both systems were knocked out was
not capable of forming biofilms in the presence of this mac-
rolide (25). Remarkable in this regard is that mexC was only
expressed in azithromycin-exposed sessile cells, whereasmexA
expressionwas observed in both exposed andunexposed plank-
tonic and sessile cells, suggesting that the P. aeruginosa
MexCD-OprJ pump is a biofilm-specific defense mechanism
against azithromycin (25). Similarly, it was suggested that the
P. aeruginosaMexAB-OprM pump provides a biofilm-specific
defense mechanism against colistin (26). These initial studies
targeting known RND-type efflux pumps already pointed to a
role for efflux in biofilm resistance, and this was further con-
firmed in a large-scale screening study in which 4000
P. aeruginosa transposon mutants were investigated (27). In
this study, the PA1874–1877 operon was identified as a novel
efflux system potentially involved in biofilm-specific resistance
to antibiotics: the expression of PA1874was found to be 10-fold
higher in sessile than in planktonic cells, deletion of the operon
only affected susceptibility to tobramycin in biofilms, and over-
expression of the operon decreased the susceptibility toward
selected aminoglycosides and fluoroquinolones in planktonic
cells (27). In addition, in Pseudomonas fluorescens, expression
of two efflux systems was up-regulated in glutaraldehyde-
treated biofilms, and efflux pump inhibitors increased sensitiv-
ity of P. aeruginosa and P. fluorescens biofilms to this disinfect-
ant, confirming that not only antibiotic resistance is mediated
by efflux (28). Finally, it was observed that planktonic P. aerugi-
nosa cells grown under hypoxic conditions showed an in-
creased expression of MexEF-OprN (29). Although biofilm
cells were not investigated in this particular study, the authors
speculate that the hypoxia encountered by P. aeruginosa bio-
films in the lungs of CF patients could contribute to their anti-
biotic resistance.
So far, little is known about the regulation of efflux pump
expression in biofilms. However, the work of Karin Sauer and
co-workers on the P. aeruginosa biofilm-specific MerR-type
transcriptional regulator BrlR points to a possible molecular
link between efflux pump expression and the biofilm pheno-
type. BrlR is a transcription factor that responds to changes in
the concentration of the secondary messenger c-di-GMP (see
Ref. 30 for a recent review as well as Ref. 31 in this minireview
series) and regulates the expression of several genes involved in
biofilm tolerance, including ndvB (32, 33). Sauer and co-work-
ers (34) also demonstrated that brlR is required for maximal
expression of the MexAB-OprM and MexEF-OprN efflux
pumps in P. aeruginosa biofilms, and demonstrated a direct
regulation of these pumps by BrlR, with BrlR binding to the
promotor regions of the mexAB-oprM and mexEF-oprN
operons.
In contrast to thework cited above, in two studies carried out
by Stewart and co-workers (35, 36), no evidencewas found for a
role of efflux pumps in tolerance of P. aeruginosa biofilms.
These at first sight contradictory findings suggest that the role
of efflux systems in protecting sessile cells against antibiotics
may depend on the global biofilm physiology (and thus on the
experimental conditions) and/or may point to the presence of
specific subpopulations in biofilms that benefit from these
efflux pumps, whereas others do not. In addition, the regulatory
mechanisms linking efflux with the biofilm-phenotype may be
strain- and condition-dependent.
Most of the above mentioned studies used antibiotic-ex-
posed P. aeruginosamutant strains to confirm the role of efflux
systems in biofilm tolerance, but the role of these systems in
P. aeruginosa biofilm formation as such (in the absence of anti-
biotics) has not been investigated in great detail. However,
using efflux pump inhibitors, including carbonyl cyanide
m-chlorophenylhydrazone, chlorpromazine, and PAN, it was
shown that in static as well as in flow conditions, efflux pump
inhibitors decreased biofilm formation, leading to the sugges-
tion that efflux pump inhibitors could be used as anti-biofilm
agents (19).
Burkholderia cenocepacia
The genome of another CF pathogen, B. cenocepacia, con-
tains genes coding for 22 RND efflux systems (37–40), and high
levels of expression of these efflux pumps are frequently
observed in B. cepacia complex clinical isolates (41). Exposure
of B. cenocepacia biofilms to the disinfectant chlorhexidine
results in the up-regulation of eight RND family efflux pumps
(42). Using mutants in which single RND efflux pumps were
inactivated, it was shown that for some mutants (e.g. the
RND-9 mutant), biofilms were less tolerant than wild type
biofilms (whereas planktonic susceptibility remaining unal-
tered). However, in other mutants (e.g. the RND-4 mutant),
planktonic cells were more susceptible, whereas the suscepti-
bility of sessile cells remained unchanged, confirming that at
least some of the RND efflux pumps in this organism are life-
style-specific (42).
Expanding on this work, the role of 16 B. cenocepacia efflux
systems in resistance to various antibiotics, including tobramy-
cin and ciprofloxacin, was subsequently investigated (43). By
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measuring susceptibility in planktonic and sessile cultures, it
was demonstrated that the RND-3 andRND-4 efflux pumps are
important for resistance to various antimicrobial drugs (includ-
ing tobramycin and ciprofloxacin) in planktonic B. cenocepacia
populations, whereas the RND-3, RND-8, and RND-9 efflux
pumps are important for protecting sessile cells against tobramy-
cin, again pointing toward the existence of life style-specific RND-
type efflux pumps. Interestingly, in the wild type strain, little reg-
ulation of expression of these efflux pumps at themRNA level was
observed using RT-quantitative PCR, suggesting that the regula-
tion occurs mainly at the posttranscriptional level and/or at the
level of activation of particular efflux systems (43).
Physiological Adaptation in Microbial Biofilms Leads to
Reduced Activity of Antimicrobial Agents: Dormancy
and the Persister Phenomenon
Bacterial populations are known to contain a subpopulation
of cells tolerant to antimicrobial treatment (6). These so-called
persister cells are present in both sessile and planktonic cul-
tures, but are especially problematic in a biofilm environment,
where they are shielded from the immune system (44, 45). Per-
sisters are notmutants, but phenotypic variants of the wild type
that upon re-inoculation produce a culture that again contains
both persister and non-persister bacteria like the original pop-
ulation (44). Unlike antibiotic-resistant bacteria, they do not
grow in the presence of bactericidal agents, but resume growth
after the antibiotics have been removed (46). Because antibiot-
ics kill cells by corrupting specific targets, dormant persisters,
in which the antibiotic targets are inactive, escape killing (46).
Non-growing or slowly growing bacteria are generally less sen-
sitive to antibiotics, a phenomenon called “drug indifference”
(45). However, persistence and drug indifference are different
phenomena: the latter reflects the overall reduced sensitivity of
dormant/slow-growing microbial populations without a spe-
cific mechanistic basis (e.g. stationary phase bacterial cultures
surviving treatment with -lactams), whereas persistence gives
rise to a subpopulation with a different phenotype (45). The
mechanisms leading to persistence are still largely unknown.
Screening knock-out libraries has not led to the identification
of mutants completely lacking the ability to form persisters,
indicating that the mechanisms involved are redundant (46).
However, various studies have identified putative persister
genes (47, 48), and a general picture starts to emerge in which
multiple (often connected) mechanisms play a role (Fig. 1).
Below we will discuss the role of stress responses and metabo-
lism, and focus on the similarities and differences between bio-
films and planktonic cultures.
FIGURE 1. Schematic overview of physiological adaptations in biofilm tolerance.
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Oxidative Stress Response
Because bactericidal antibiotics are known to induce oxida-
tive stress (49), lowering cellular hydroxyl radical levels by
decreasing their production or by increased detoxification
could counteract bactericidal activity. Shatalin et al. (50)
showed in both biofilms and stationary phase cultures of vari-
ous bacteria that H2S induced tolerance by reducing oxidative
stress, through sequestration of ferrous iron and stimulation of
catalases and superoxide dismutases. Similarly, it was observed
that the active lowering of cellular hydroxyl levels played a role
in planktonic and sessile P. aeruginosa persistence during star-
vation (51). Activation of the stringent response increased cat-
alase and superoxide dismutase levels and repressed the pro-
duction of hydroxy-alkylquinolines, intercellular signaling
molecules with pro-oxidant properties (51). Data obtained for
tobramycin-treated B. cenocepacia biofilms confirmed that
avoiding exposure to antibiotic-induced reactive oxygen spe-
cies (ROS) is a key factor in survival of persisters in these bio-
films (52). Several genes encoding proteins involved in the gen-
eration of ROS, including a ferredoxin reductase (involved in
recycling Fe3 to Fe2 and thus driving the Fenton reaction),
were found to be down-regulated in persisters, whereas genes
encoding proteins involved in ROS detoxification were up-reg-
ulated. These results suggest that persisters are to some extent
protected against the detrimental effects of ROS produced
upon antibiotic treatment.
The Stringent Response
Several studies have specified a role for guanosine tetra- or
pentaphosphate, (p)ppGpp (known as the “alarmone”), the cen-
tral mediator of the stringent response, in persistence (53–56).
The relA-spoT gene pair, involved in the synthesis of (p)ppGpp,
was linked to persistence in various studies (57–59). For exam-
ple, reduced levels of persisters were reported in P. aeruginosa
biofilms deficient in (p)ppGpp synthesis (36). Gerdes et al. (53)
proposed a model in which (p)ppGpp induces persistence by
activating toxin antitoxin (TA) modules via polyphosphate and
Lon proteases. It was previously demonstrated that deletion of
lon dramatically reduces persistence, whereas amoderate over-
production stimulates persistence by degrading antitoxins and
hereby activating their cognate toxins (60). A link between
(p)ppGpp and the transcriptional activation of the toxin HokB
byObg, a universally conservedGTPase, was recently identified
(61). Obg was shown to control persistence, in both planktonic
cultures and P. aeruginosa biofilms, by inducing the expression
ofHokB,whereas elevated levels ofHokB resulted inmembrane
depolarization and dormancy.
TAModules
TAmodules are thought to be amajor player in the induction
of persistence (53) (for a review on TA modules, see Ref. 62).
Type II TAmodules usually consist of two proteins: a toxin that
can inhibit an important cellular function and an antitoxin that
can form a complex with the toxin and hence inactivates it (63)
(Fig. 2) (for a schematic overview of the different types of TA
modules, see supplemental Fig. S2). The antitoxin is typically
proteolytically degraded during stress, and as a result, the free
toxin can impede cellular processes such as DNA replication,
translation, ATP, or cell wall synthesis (53, 64). TA modules,
although initially thought to be involved only in cell death, have
been shown to play a role in various essential cellular processes,
including biofilm formation and persistence (53). Because bac-
tericidal antibiotics kill cells by corrupting cellular functions,
which are inhibited by toxins, the role of TAmodules in persis-
tence has been documented in various studies (53). Toxin inhi-
bition of cell wall synthesis, translation, or replication would
prevent antibiotics from killing and give rise to persister cells.
HipAB was the first TA module linked to persistence (65), and
many key insights on persistence were obtained while studying
this particular module. Rotem et al. (66) noticed that persis-
tence occurred once the toxinHipA reached a certain threshold
level and that the amount by which the threshold was exceeded
determined the duration of dormancy. Since the identification
ofHipAB, various studies have reported an up-regulation of TA
modules in persister cells (65, 67). For example, transcriptome
analysis of dormant E. coli cells identified mqsR as the most
highly induced gene in persister cells as compared with non-
persisters (67). In B. cenocepacia, several toxins were found to
be up-regulated in biofilms as compared with planktonic cells,
and overexpression of these toxins contributed to persistence
in biofilms after treatment with tobramycin or ciprofloxacin
(68). Although overproduction of almost any toxin may
increase persistence, only two TA pairs have been shown to
decrease persistence upon deletion (69, 70). Deletion ofmqsRA
significantly reduced persistence in E. coli biofilms (69),
whereas deletion of tisAB/istr1 led to a decrease in survival in
planktonic cultures (70). Simultaneous deletion of multiple
other TA systems also decreased the number of persisters in
E. coli (60). The latter confirms the role of TA modules in per-
sistence, but again suggests redundancy.
Additionally, recent studies have indicated a role for TA sys-
tems in the switch from the planktonic to the sessile lifestyle.
MqsRAwas the first TAmodule linked to biofilm formation: in
a transcriptome study comparing sessile and planktonic cells,
mqsR was found to be induced in biofilms (71), and biofilm
formation inE. coliwas found to bemediated byMqsRA (72). In
support of these observations, the antitoxin MqsA was more
recently found to repress rpoS, thereby reducing the c-di-GMP
concentration, which leads to increasedmotility and decreased
biofilm formation (69). Degradation of MqsA by Lon proteases
in turn resulted in rpoS induction and a switch from the plank-
FIGURE 2. Schematic overview of type II TAmodules.
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tonic to the biofilm state. Amodel was proposed in which there
is a spectrum of MqsR activities, and depending on the activity
of MqsR, a cell would respond to stress by biofilm formation
and the production of proteins to withstand stress, or alterna-
tively, become dormant (69). In this regard, persister cell for-
mation can be seen as an extreme example of the general stress
response mediated by MqsR. Further evidence for the involve-
ment of TA modules in E. coli biofilm formation was obtained
by studying5, a strain inwhich five differentTAmoduleswere
deleted. Deletion of these systems reduced biofilm formation
after 8 h but increased biofilm formation after 24 h (73). Tran-
scriptome profiling revealed that deletion of these TAmodules
induced the expression of an uncharacterized gene, yjgK, which
repressed fimbriae at 8 h (73). Although this repression of fim-
briae may explain the decrease in biofilm formation at 8 h, a
reduction in biofilm dispersal may explain the increase in bio-
film formation at 24 h.
The SOS Response
The SOS response is triggered by DNA damage (74). This
damage is recognized by RecA, which causes self-cleavage of
the LexA repressor, hereby activating SOS genes (74). Based on
transcriptome analyses and screening of mutant libraries, lexA
and recA were found to be involved in E. coli persistence (58,
65). In line with this observation, deletion of the tisAB/istr1TA
module, which contains a Lex box, dramatically reduced the
number of surviving persisters in exponentially growing cul-
tures of E. coli treated with fluoroquinolones, but not after
treatment with antibiotics that do not cause DNA damage (70).
Moreover, a functional RecA protein was needed for persis-
tence, confirming dependence on the SOS pathway. The induc-
tion of persisters by the SOS-induced TisB toxin links two sur-
vival strategies, i.e. active repair on the one hand and shutdown
of cellular metabolism on the other. This suggests that in the
presence of DNA-damaging agents, the optimal strategy is to
induce repair and at the same time increase the number of
dormant cells that will survive when repair would fail (46).
Interestingly, although inactivation of genes involved in the
SOS response also increased susceptibility to fluoroquinolones
in stationary phase cultures, TisB was not found to be involved,
suggesting that persisters form through other mechanisms in
non-growing cultures (70). Tolerance to ofloxacin significantly
increased inE. coli biofilms upon starvation, whereas starvation
did not have a significant effect on tolerance to ofloxacin in
planktonic cultures (75). Similarly, tolerance was dependent on
the SOS response but independent of known SOS-induced TA
modules. Although starvation also induces the stringent
response, deletion of relA only partially increased sensitivity to
ofloxacin and only upon leucine starvation, suggesting that the
stringent response plays a minor role in tolerance to ofloxacin.
Metabolism
A regulator of phosphate metabolism, phoU, was identified
as a persister gene as its deletion reduced persistence in plank-
tonic cultures of E. coli and inactivation of phoU was shown to
lead to a hyperactive metabolic state (76). However, mutations
in sucB or ubiF, leading to reduced ATP synthesis, also nega-
tively affected survival of persisters (77). SucB is a key enzymeof
the TCA cycle, whereas UbiF is involved in the biosynthesis of
ubiquinone, an acceptor of electrons in the respiratory electron
transport chain. These at first sight contradictory results illus-
trate the critical role regulation of metabolismmay play in per-
sistence. Based onpersistence assays andFACS sorting ofE. coli
cells fluorescently labeled according to their metabolic activity,
Orman and Brynildsen (78) suggested that a low metabolic
activity prior to antibiotic exposure only increases the likeli-
hood of a cell to become a persister. Additionally, they observed
that inhibition of respiration decreased the number of persist-
ers surviving treatment with ampicillin (79). Inhibition of res-
piration during stationary phase may prevent digestion of
endogenous proteins andmRNAand thus allow translation and
replication to proceed and render bacteria susceptible to anti-
biotics. In B. cenocepacia biofilms, a metabolic shift bypassing
the TCA cycle was observed in persister cells (52). In cells sur-
viving treatment with tobramycin, genes encoding proteins
involved in the TCA cycle were down-regulated, and at the
same time, the glyoxylate shunt was activated, most likely to
sustain ATP production. Mok et al. (80) studied the metabolic
aspects of persisters in an E. coli strain in which the antitoxin
MazE and the toxin MazF were artificially and independently
induced. Upon accumulation of MazF, an endoribonuclease,
reversible stasis was achieved and populations were almost
entirely tolerant to fluoroquinolones and -lactams. Although
these induced persisters were found to be non-replicative, they
maintained oxygen and glucose consumption. Further analysis
also indicated accumulation of all four ribonucleotide mono-
phosphates, confirming futile cycling in these persisters.
Energy derived from catabolism was used to continue tran-
scription, but at the same time, the transcripts were degraded
by MazF.
An obvious question is whether or not persister cells can be
considered as dormant, given the mechanisms involved. Based
on studies indicating the role of different stress responses in
persister cells, it was suggested that persistence is an actively
maintained state (81). However, according to Wood et al. (82),
most evidence points to a role for dormancy, toxin induction,
down-regulation of metabolic pathways, and shutdown of pro-
tein synthesis in persistence. Although both viewpoints seem
contradictory, they could be reconciled as active responses
to stress may play a role in inducing dormancy because most
stress responses lead to slowing down or inhibition of cell
growth (81, 82). Additionally, although shutdown of meta-
bolic processes may be involved in the entry into a dormant
antibiotic tolerant state, residual metabolic activity may be
required to maintain viability, and reactivation is necessary
to resume growth after removal of the antibiotics (for recent
reviews on targeting metabolism, see Refs. 83 and 84). For
example, in stationary phase cultures of E. coli, there is no
difference in DNA damage between persisters and non-per-
sisters (85). Moreover, neither the level of SOS machinery
before nor during treatment impacted the level of persisters,
but the cell’s ability to repair ofloxacin-induced DNA dam-
age during recovery when the antibiotic was removed was
critical to maintain persistence.
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Concluding Remarks
Manydifferentmechanisms leading to biofilm resistance and
tolerance have been described, including efflux-mediated
removal of antimicrobial agents from the cytoplasm and the
occurrence of tolerant and persistent subpopulations of cells.
Although there is currently no evidence linking increased efflux
in bacterial populations with cell density, it is clear that at
least in some bacterial species particular efflux systems are
involved in biofilm formation and/or resistance. The currently
available evidence suggests that life style-specific efflux pumps (i.e.
efflux systems that are preferentially used in either planktonic or
sessile populations) exist, as well as general systems that are used
by bacteria to get rid of unwanted compounds irrespective of the
modeofgrowth.Little isknownabout the regulationof theexpres-
sion of these efflux pumps and how that would be affected by
growth in a biofilm, although work with the regulator BrlR in
P. aeruginosa points to a role for c-di-GMP.
Persister cells have beendescribed in all bacteria examined so
far, and persisters present in biofilms are thought to be an
important reason for treatment failure. Persisters are generally
considered as dormant cells in which the antibiotic targets are
inactive. Recent research, however, suggest that persisters are
not necessarily inactive but rather have a different metabolism.
Several studies points to the importance of residual metabolic
activity to maintain viability and the ability to resuscitate after
removal of the antibiotics. Additionally, active responses to
stress are thought to induce persistence, and different stress
responses are likely involved depending on the conditions.
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